Posts Tagged ‘Savonix’
Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers
_______ The hunt for behavioral health biomarkers is harnessing digital health at the research stage (MedCity News): “Digital health companies are going through an interesting transformation as research institutions realize the benefit of their technology to collect and manage data for a host of studies. The biopharma industry’s embrace of some digital health tools to manage…
Read MoreE‑Newsletter: Neuroimaging + machine learning can predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2
_____ Time for SharpBrains’ June e‑newsletter, featuring fascinating scientific findings, promising assessments, therapies and brain health monitoring tools…and some fun optical illusions :-) New research Study combines neuroimaging with machine learning to predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2 Cognitive Training or Gingko Biloba to prevent cognitive decline and…
Read MoreDigital brain health goes global: Savonix raises $5.1 million to commercialize mobile neurocognitive assessment in the US, China and Japan
— Savonix gets $5.1M to advance digital neurocognitive assessment (MobiHealth News): “San Francisco-based Savonix, maker of an app for neurocognitive assessment, has raised $5.1 million in a new round of funding. DigiTx Partners led the round with additional contribution from ReThink Impact.
Read More